Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats

References

• BrayF, FerlayJ, SoerjomataramI, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• CorreaP. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–3560.3288329
   PubMed Web of Science ®Google Scholar
• de VriesAC, van GriekenNC, LoomanCW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952. doi:10.1053/j.gastro.2008.01.07118395075
   PubMed Web of Science ®Google Scholar
• YoonH, KimN. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5–17. doi:10.5009/gnl1411825547086
   PubMed Web of Science ®Google Scholar
• HuangL, WuRL, XuAM. Epithelial-mesenchymal transition in gastric cancer. Am J Transl Res. 2015;7:2141–2158.26807164
   PubMed Web of Science ®Google Scholar
• BalkwillF, MantovaniA. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. doi:10.1016/S0140-6736(00)04046-011229684
   PubMed Web of Science ®Google Scholar
• DiakosCI, CharlesKA, McMillanDC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• CandidoJ, HagemannT. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):S79–S84. doi:10.1007/s10875-012-9847-023225204
   PubMed Web of Science ®Google Scholar
• MantovaniA, AllavenaP, SicaA, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• RuiLX, ShuSY, JunWJ, et al. The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-kappaB pathway. Tumour Biol. 2016;37:5133–5144. doi:10.1007/s13277-015-4293-226547583
   PubMedGoogle Scholar
• ShishodiaS, KoulD, AggarwalBB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol. 2004;173:2011–2022. doi:10.4049/jimmunol.173.3.201115265936
   PubMed Web of Science ®Google Scholar
• LinEY, PollardJW. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007;67:5064–5066. doi:10.1158/0008-5472.CAN-07-091217545580
   PubMed Web of Science ®Google Scholar
• HanTS, HurK, XuG, et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut. 2015;64:203–214. doi:10.1136/gutjnl-2013-30664024870620
   PubMed Web of Science ®Google Scholar
• HuY, LiuJP, LiXY, et al. Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin beta-1/NF-kappaB signaling pathway. Cancer Lett. 2019;450:144–154. doi:10.1016/j.canlet.2019.02.03930849478
   PubMed Web of Science ®Google Scholar
• ZhuS, SouttoM, ChenZ, et al. Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32. Gut. 2017;66:761–762. doi:10.1136/gutjnl-2016-312141
   PubMed Web of Science ®Google Scholar
• LiangH, KimYH. Identifying molecular drivers of gastric cancer through next-generation sequencing. Cancer Lett. 2013;340:241–246. doi:10.1016/j.canlet.2012.11.02923178814
   PubMed Web of Science ®Google Scholar
• GiraudAS, MenheniottTR, JuddLM. Targeting STAT3 in gastric cancer. Expert Opin Ther Targets. 2012;16:889–901. doi:10.1517/14728222.2012.70923822834702
   PubMed Web of Science ®Google Scholar
• JuddLM, BredinK, KalantzisA, et al. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology. 2006;131(4):1073–1085. doi:10.1053/j.gastro.2006.07.01817030178
   PubMed Web of Science ®Google Scholar
• GuoT, LiuZ-L, ZhaoQ, et al. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo. Acta Pharmacol Sin. 2018;39(9):1483–1492. doi:10.1038/aps.2017.17529849130
   PubMed Web of Science ®Google Scholar
• ZhangYY, TanRZ, ZhangXQ, et al. Calycosin ameliorates diabetes-induced renal inflammation via the NF-kappaB pathway in vitro and in vivo. Med Sci Monit. 2019;25:1671–1678. doi:10.12659/MSM.91524230830898
   PubMed Web of Science ®Google Scholar
• WangQ, LuW, YinT, et al. Calycosin suppresses TGF-beta-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells. J Exp Clin Cancer Res. 2019;38:240. doi:10.1186/s13046-019-1243-731174572
   PubMed Web of Science ®Google Scholar
• QiuR, LiX, QinK, et al. Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism. Biofactors. 2019;45:975–982. doi:10.1002/biof.154531322783
   PubMed Web of Science ®Google Scholar
• NieXH, Ou-yangJ, XingY, et al. Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells. Drug Des Devel Ther. 2016;10:767–779. doi:10.2147/DDDT.S90457
   PubMed Web of Science ®Google Scholar
• ZhouL, WuY, GuoY, et al. Calycosin enhances some chemotherapeutic drugs inhibition of Akt signaling pathway in gastric cells. Cancer Invest. 2017;35:289–300. doi:10.1080/07357907.2016.127822628368679
   PubMed Web of Science ®Google Scholar
• CaiT, ZhangC, ZhaoZ, et al. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats. Biomed Pharmacother. 2018;104:291–299. doi:10.1016/j.biopha.2018.04.01329775897
   PubMed Web of Science ®Google Scholar
• ZengJ, YanR, PanH, et al. Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions. BMC Complement Altern Med. 2018;18:250. doi:10.1186/s12906-018-2309-330200948
   PubMed Web of Science ®Google Scholar
• ZhangC, CaiT, ZengX, et al. Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: regulation on glycolysis through miRNA-34a/LDHA pathway. Phytother Res. 2018;32:1364–1372. doi:10.1002/ptr.607029577459
   PubMed Web of Science ®Google Scholar
• ChenZ, ZhuS, HongJ, et al. Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis. Gut. 2016;65:925–934. doi:10.1136/gutjnl-2014-30841625779598
   PubMed Web of Science ®Google Scholar
• ZhuS, SouttoM, ChenZ, et al. Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells. Oncogene. 2019;38:5805–5816. doi:10.1038/s41388-019-0843-131235784
   PubMed Web of Science ®Google Scholar
• SmolinskaM, GrzankaD, AntosikP, et al. HER2, NF-kappaB, and SATB1 expression patterns in gastric cancer and their correlation with clinical and pathological parameters. Dis Markers. 2019;2019:6315936. doi:10.1155/2019/631593631737131
   PubMed Web of Science ®Google Scholar
• CorreaP. Human gastric carcinogenesis: a multistep and multifactorial process–first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–6740.1458460
   PubMed Web of Science ®Google Scholar
• SungJK. Diagnosis and management of gastric dysplasia. Korean J Intern Med. 2016;31:201–209. doi:10.3904/kjim.2016.02126932397
   PubMed Web of Science ®Google Scholar
• XuZY, ChenJS, ShuYQ. Gene expression profile towards the prediction of patient survival of gastric cancer. Biomed Pharmacother. 2010;64:133–139. doi:10.1016/j.biopha.2009.06.02120005068
   PubMed Web of Science ®Google Scholar
• ZhaoZS, LiL, WangHJ, et al. Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer. J Surg Oncol. 2011;104:525–529. doi:10.1002/jso.2198421618249
   PubMed Web of Science ®Google Scholar
• UhmJH, GladsonCL, RaoJS. The role of integrins in the malignant phenotype of gliomas. Front Biosci. 1999;4:D188–D199. doi:10.2741/Uhm9989953
   PubMedGoogle Scholar
• ParkCC, BissellMJ, Barcellos-HoffMH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000;6:324–329. doi:10.1016/S1357-4310(00)01756-110904250
   PubMedGoogle Scholar
• WeaverVM, LelievreS, LakinsJN, et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2002;2:205–216. doi:10.1016/S1535-6108(02)00125-312242153
   PubMed Web of Science ®Google Scholar
• KarinM. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009;1:a000141. doi:10.1101/cshperspect.a00014120066113
   PubMed Web of Science ®Google Scholar
• SokolovaO, NaumannM. NF-kappaB signaling in gastric cancer. Toxins (Basel). 2017;9. doi:10.3390/toxins9040119
   PubMed Web of Science ®Google Scholar
• HW PHL, ZhaoZM, ShiYF, et al. Effect of weipixiao on plasma tumor necrosis factor alpha and interleukin-4 expression in rats with gastric precancerous lesions. J Guangzhou Univ Trait Chin Med. 2015;32:271–274.
   Google Scholar
• KawamuraT, EndoY, YonemuraY, et al. Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model. Int J Oncol. 2001;18:809–815.11251178
   PubMed Web of Science ®Google Scholar
• El-RifaiW, SmithMF Jr, LiG, et al. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res. 2002;62:4061–4064.12124342
   PubMed Web of Science ®Google Scholar
• MukherjeeK, PengD, BrifkaniZ, et al. Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery. 2010;148:354–363. doi:10.1016/j.surg.2010.05.01120580047
   PubMed Web of Science ®Google Scholar
• AlveroAB, ChenR, FuHH, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle. 2009;8:158–166. doi:10.4161/cc.8.1.753319158483
   PubMed Web of Science ®Google Scholar
• JiY, WangZ, LiZ, et al. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells. Cell Physiol Biochem. 2012;29(5–6):863–874. doi:10.1159/00017103422613986
   PubMedGoogle Scholar
• ZhaoM, GaoFH, WangJY, et al. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer. Lung Cancer. 2011;73:366–374. doi:10.1016/j.lungcan.2011.01.00221333372
   PubMed Web of Science ®Google Scholar
• AtkinsonGP, NozellSE, BenvenisteET. NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother. 2010;10:575–586. doi:10.1586/ern.10.2120367209
   PubMed Web of Science ®Google Scholar
• YuH, PardollD, JoveR. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809.19851315
   PubMed Web of Science ®Google Scholar
• WangXY, WangLL, ZhengX, et al. Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol. 2016;8:305–313. doi:10.4251/wjgo.v8.i3.30526989466
   PubMed Web of Science ®Google Scholar
• YuH, JoveR. The STATs of cancer–new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105. doi:10.1038/nrc127514964307
   PubMed Web of Science ®Google Scholar
• BrombergJ, WangTC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15:79–80. doi:10.1016/j.ccr.2009.01.00919185839
   PubMed Web of Science ®Google Scholar
• McFarlandBC, GrayGK, NozellSE, et al. Activation of the NF-kappaB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells. Mol Cancer Res. 2013;11:494–505. doi:10.1158/1541-7786.MCR-12-052823386688
   PubMed Web of Science ®Google Scholar
• LentschAB, WardPA. Regulation of inflammatory vascular damage. J Pathol. 2000;190:343–348. doi:10.1002/(SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M10685068
   PubMed Web of Science ®Google Scholar
• WhitefordJR, De RossiG, WoodfinA. Mutually supportive mechanisms of inflammation and vascular remodeling. Int Rev Cell Mol Biol. 2016;326:201–278.27572130
   PubMed Web of Science ®Google Scholar
• BidHK, OswaldD, LiC, et al. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12. PLoS One. 2012;7:e35513. doi:10.1371/journal.pone.003551322530037
   PubMed Web of Science ®Google Scholar
• HuangC, JiangT, ZhuL, et al. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Int J Oncol. 2011;38:1637–1644. doi:10.3892/ijo.2011.100021479358
   PubMed Web of Science ®Google Scholar
• QianWF, GuanWX, GaoY, et al. Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma. Braz J Med Biol Res. 2011;44:1222–1230. doi:10.1590/S0100-879X201100750014322030865
   PubMed Web of Science ®Google Scholar
• EfferthT, ShanL, ZhangZW. Tonic Herbs and Herbal Mixtures in Chinese Medicine. World J Tradit Chin Med. 2016;1:10–25. doi: 10.15806/j.issn.2311-8571.2015.0037
   Google Scholar
• DiviRL, ChangHC, DoergeDR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997;54:1087–1096. doi:10.1016/S0006-2952(97)00301-89464451
   PubMed Web of Science ®Google Scholar
• SarteletH, SerghatS, LobsteinA, et al. Flavonoids extracted from fonio millet (Digitaria exilis) reveal potent antithyroid properties. Nutrition. 1996;12:100–106. doi:10.1016/0899-9007(96)90707-88724380
   PubMed Web of Science ®Google Scholar